人事变动 OpenAI 挖走了企业软件领域最资深的高管之一。 去年 11 月，CEO Sam Altman 透露，OpenAI 在未来八年内将承担高达 1.4 万亿美元的采购与算力承 诺，引发部分投资者与行业观察者的担忧：其商业模式是否能支撑如此宏大的扩张雄心？ 与此同时，ChatGPT Android 公开测试版的代码显示，其中已出现可能的广告模块，或将伴随搜索、电 商等查询结果展示。 收入多元化布局 OpenAI 高管一直在释放信号，计划将收入来源从企业授权之外进一步多元化，包括广告、分级订阅、 以及更结构化的商业化产品包等方向。 "我们正在让 AI 工具进入各行各业、数以百万计的职场人手中。"OpenAI 应用业务 CEO Fidji Simo 在 博客中写道，"Denise 曾推动过这样的行业级变革，她的经验将帮助我们让 AI 对全球企业变得更有 用、更可靠、更容易获得。" Dresser 担任 Slack CEO 的时间超过两年。在此之前，她在 Salesforce 企业销售体系内任职逾 14 年，担 任多个高级职位。她是在前任 CEO Lidiane Jones 离职（前往 Bumble 出任 C ...

经济观察网证监会网站显示，全芯智造技术股份有限公司2025年12月11日向安徽证监局办理辅导备案登 记，辅导机构为国泰海通证券股份有限公司。 ...

2025年12月9日，河北证监局对长城人寿采取了出具警示函的行政监管措施，原因是长城人寿买入二级市场股票达5%触发举牌时，未能及时停止买卖。 在多部门联合出台政策鼓励长期资金入市的背景下，长城人寿是险资增持资本市场的一股活跃力量。 作为一家成立20年、资产规模超过1600亿元的寿险公司，长城人寿是典型的中型保险公司发展观察样本。该公司有着差异化的竞争策略——致力于成为"中 国家庭风险保障服务商"，但其更为市场所熟知的，是在资本市场的纵横捭阖。 一路在二级市场举牌加仓的长城人寿保险股份有限公司（下称"长城人寿"）接到了来自证监局的警示函。 随着利率水平的持续下行，背负着大量高资金成本保单的保险公司不得不寻找优质资产，增加权益类资产成了他们的共同选择。但这也给保险公司带来了资 本承压、利润波动的挑战。 加仓能手因举牌不当被点名 根据警示函，长城人寿于2025年9月23日增持新天绿色能源股份有限公司（下称"新天绿能"）股票100万股，增持后合计持有新天绿能股票21040万股，占新 天绿能总股本的5.0027%。在持有新天绿能股份达到5%时，未停止买卖新天绿能股份，违反了《中华人民共和国证券法》第三十六条第二款、第六 ...

Core Insights - The report by iResearch highlights Ant Group's technology leadership and practical application capabilities in the financial AI sector, placing it in the comprehensive leader quadrant [1] Industry Summary - iResearch predicts that by the end of 2028, 80% of financial institutions will adopt at least one AI tool [1] - More than 35% of financial AI applications are expected to reach a scalable implementation phase during this period, indicating the industry's transition into a phase of scale expansion [1]

经济观察报记者 郑晨烨 备受资本市场关注的国产算力产业"A吃A"重组案例——海光信息（688041.SH）拟换股吸收合并中科曙光（603019.SH）——在筹划半年后宣告终止。 12月9日晚间，海光信息与中科曙光同步发布公告，宣布终止筹划重大资产重组事项。受该消息影响，12月10日开盘，中科曙光股价直接封死跌停板，截 至收盘报90.12元/股，总市值回落至1318.56亿元；海光信息股价表现相对平稳，收报218.50元/股，微跌0.36%，总市值5078.68亿元。 针对此次事项终止的具体原因、重组所遭遇的障碍以及后续业务模式的调整，在12月10日召开的终止重大资产重组投资者说明会上，海光信息董事、总经 理沙超群向经济观察报记者做出了详细回应。 市场环境变化与"各方视角" 回溯此次重组的起点，2025年5月26日，海光信息与中科曙光分别发布公告，筹划由海光信息通过向中科曙光全体A股换股股东发行A股股票的方式，换股 吸收合并中科曙光，同时发行A股股票募集配套资金。 根据后续披露的预案，中科曙光的换股价格定为79.26元/股，海光信息的换股价格为143.46元/股，换股比例为0.5525:1（即1股中科曙光换0. ...

本文为【ESG真心话】系列报道第十八篇。 专题第十八篇 这一次，我们将目光对准上市公司，对准ESG。今日，任何一家企业的竞争力都不再仅仅局限于财务因素。 ESG（Environmental,Social and Governance，即环境、社会和公司治理）方面的非财务因素正在发挥作用，甚至可以说，是决定性的作用。 但在国内，ESG体系的构建，起步较晚。甚至有的企业这方面的意识也才刚刚觉醒。在采访中，一位国企人士依然充满疑惑："我为什么要做ESG？" 近一年多来，不同部门陆续出台与ESG相关的新政和指引，财政部、生态环境部等部门，也在酝酿下一步推动ESG的政策文件。 到2027年，包括财政部在内的国家部委，将陆续出台国内相关企业的可持续披露基本准则、气候相关披露准则。到2030年，国家统一的可持续披露准则体系 要基本建成。 自上而下的推动，也催生着ESG市场的火热。 我们会持续关注ESG的发展，邀请相关人士探讨关于ESG的真问题。 施义：ESG不是"评分游戏" 经济观察报记者 王雅洁 从瑞士到中国，施义一直在关注着ESG（环境、社会和公司治理）投资如何超越字母游戏与分数比拼，真正触及企业运营与社会发展的内核。 ...

经济观察网 据央视新闻客户端消息，记者从自然资源部获悉，受冷空气影响，预计今天（10日）夜间 至明天（11日）下午，渤海湾和莱州湾将出现70到150厘米的风暴增水，渤海、黄海北部将出现2.5到3.8 米的大浪区。国家海洋预报台发布风暴潮蓝色警报，同时继续发布海浪蓝色警报。请在上述海域作业的 船只注意安全，沿海各有关单位提前采取防浪避浪措施。 ...

Group 1 - The Consumer Price Index (CPI) in November increased by 0.7% year-on-year, marking the highest level in 2023 and since March 2024 [1] - Urban CPI rose by 0.7%, while rural CPI increased by 0.4%. Food prices saw a 0.2% rise, and non-food prices increased by 0.8% [1] - The increase in CPI is attributed to seasonal price rebounds in food items, particularly fresh vegetables, which contributed significantly to the CPI's upward movement [2][4] Group 2 - Core CPI remains resilient despite a slight month-on-month decline of 0.1%, maintaining a year-on-year growth rate of 1.2% [2] - The rise in core CPI is supported by increasing gold prices and the effects of domestic demand expansion policies, which have led to price increases in household goods and clothing [2][4] - The potential for sustained improvement in CPI relies on continued policy support, particularly in stimulating consumption in sectors like dining and tourism [4] Group 3 - The Asian economy is expected to shift towards a more balanced and sustainable growth model by 2025, with inflation projected to decline significantly due to falling food prices [3] - A low inflation environment in 2026 may support a continued easing of monetary policy across several Asian countries, including China, which could create investment opportunities [3] - The main macroeconomic risk for Asia is not high inflation but the combination of deflationary pressures and high real policy rates, which could hinder economic recovery [3]

Core Insights - The National Healthcare Security Administration (NHSA) has officially released the first version of the "Commercial Health Insurance Innovative Drug Directory," incorporating 19 high-value, expensive innovative drugs into the commercial health insurance payment framework for the first time [1][2] - The introduction of this directory marks a significant step in improving China's multi-tiered medical security system and transforming the role of commercial insurance [1] Group 1: Directory Overview - The directory includes 19 drugs, of which 14 are anti-tumor drugs (including all 5 CAR-T therapies available in China), 2 are rare disease medications, and 2 are new drugs for Alzheimer's disease [1] - The structure of the directory aligns closely with current claims data from commercial health insurance, as malignant tumors are the most prevalent and costly disease area in China [1] Group 2: Policy Support - The drugs listed in the commercial health insurance innovative drug directory are exempt from self-payment rate assessments, do not fall under centralized procurement monitoring, and are not included in the Diagnosis-Related Group (DRG) payment scope, referred to as the "three exclusions" policy [2] - This policy alleviates the challenges hospitals face in using innovative drugs amid pressures from centralized procurement and DRG payment reforms [2] Group 3: Implementation Challenges - The transition from policy text to patient benefits requires overcoming three key barriers: standardization and inclusivity of the directory, payment coordination and bargaining power, and service fluidity and one-stop experience [2][3][4] - The current directory serves as a guiding list rather than a mandatory coverage requirement for commercial insurance products, necessitating efforts to make core drugs standard features in commercial health insurance, especially in inclusive "benefit insurance" products [3] Group 4: Payment and Service Integration - The commercial health insurance market is fragmented, with varying funding levels and coverage across different regions, which raises uncertainties about its ability to negotiate effectively with pharmaceutical companies [3] - Establishing a regional or national commercial insurance procurement coordination mechanism is essential for negotiating better drug prices and conditions, ensuring financial sustainability of coverage plans [3][4] - The ideal multi-tiered payment system should enable seamless integration and immediate settlement among basic medical insurance, commercial insurance, and out-of-pocket expenses, which currently requires patients to prepay and navigate complex claims processes [4]

Core Viewpoint - JD Industrial aims to transform the industrial supply chain by providing a comprehensive digital supply chain solution, enhancing efficiency and collaboration for global industrial enterprises [1][5][14] Group 1: Global Supply Chain Strategy - JD Industrial is establishing a global supply chain network, focusing on Southeast Asia, to support Chinese enterprises in their international expansion [3][4] - The company emphasizes the importance of local adaptation and collaboration with local suppliers and logistics partners to enhance service capabilities [4][11] - JD Industrial's strategy includes a "light operation" approach, leveraging existing logistics infrastructure while integrating local supply chains [11][12] Group 2: Digital Transformation and Technology - The company utilizes its proprietary digital supply chain management system, "Tai Pu," to optimize procurement and operational efficiency [12][13] - JD Industrial has developed the Joy Industrial model, which leverages extensive data to improve supply chain processes and reduce costs for clients [12][13] - The "trillion-dollar cost reduction" initiative aims to lower the total cost of China's industrial supply chain through digital transformation [12][13] Group 3: Challenges and Opportunities - Chinese enterprises face significant challenges when expanding overseas, including supply chain visibility and local market adaptation [7][8] - JD Industrial identifies Southeast Asia as a promising market due to its geographical advantages and supportive government policies for industrialization [6][10] - The company acknowledges the complexities of different market regulations and cultural practices, which necessitate a tailored approach to business development [4][6]